TY - JOUR T1 - Correspondence on ‘2018 update of the EULAR recommendations for the management of hand osteoarthritis’ JF - Annals of the Rheumatic Diseases JO - Ann Rheum Dis DO - 10.1136/annrheumdis-2020-218887 SP - annrheumdis-2020-218887 AU - Young Sun Suh AU - Hyun-Ok Kim AU - Chang Han Lee AU - Chul Ho Yoon AU - Yun-Hong Cheon AU - Mingyo Kim AU - Hanna Lee AU - Sang-Il Lee Y1 - 2020/10/20 UR - http://ard.bmj.com/content/early/2020/10/19/annrheumdis-2020-218887.abstract N2 - We were inspired by reading the article entitled ‘2018 update of the EULAR recommendations for the management of hand osteoarthritis’ by Kloppenburg et al.1 This up-to-date guideline will inform all health professionals and patients about optimal management by shared decision-making and may help advance research of hand osteoarthritis (OA). In overarching principles, this recommendation highlighted that the primary goal of managing hand OA is to control pain and stiffness and to optimise hand function and quality of life. This guideline also emphasised that management of hand OA should be individualised, taking into account its localisation and severity as well as comorbidities. The comorbidities should be thoroughly evaluated for individualised management of hand OA. Particularly, systemic diseases such as cardiac disease and/or hypertension, diabetes and depression are commonly accompanied with OA.2 Apart from systemic diseases, various localised upper extremity musculoskeletal diseases (UEMDs) also contribute to greater pain and poor performance-based physical function in people with hand OA. However, there have been few small studies in which carpal tunnel syndrome (CTS) or rotator cuff tear (RCT) has been commonly associated with hand OA.3 4 Moreover, … ER -